SCHEDULE 13G/A: BlackRock, Inc. Discloses 12.5% Passive Stake in QuidelOrtho Corp.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 12.5% beneficial ownership stake in QuidelOrtho Corp. as of December 31, 2024.

Summary

• BlackRock, Inc. reported beneficial ownership of 8,440,215 shares of QuidelOrtho Corp. common stock.
• This ownership represents 12.5% of the total outstanding common stock of QuidelOrtho Corp.
• BlackRock, Inc. holds sole voting power over 8,267,933 shares and sole dispositive power over 8,440,215 shares.
• The filing is an Amendment No. 4 to a previous Schedule 13G, indicating an update to an existing passive stake.
• The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of QuidelOrtho Corp.
• iShares Core S & P Small-Cap ETF, an entity associated with BlackRock, Inc., is noted to have an interest exceeding five percent of the total outstanding common stock.
• BlackRock Fund Advisors, another BlackRock entity, also beneficially owns 5% or greater of the outstanding shares of the security class.

Sentiment

Score: 6

Explanation: The filing is a routine disclosure of a passive ownership stake by a major institutional investor, BlackRock, Inc., which is generally a neutral to slightly positive indicator of institutional interest and liquidity for the stock.

Positives

• Significant institutional ownership by BlackRock, Inc., a major global asset manager, which can be interpreted as a sign of confidence or liquidity in QuidelOrtho Corp.

Future Outlook

This Schedule 13G filing does not contain any forward-looking statements or guidance regarding QuidelOrtho Corp.'s future performance or BlackRock's investment strategy beyond its passive nature.

Management Comments

• "The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11."

Industry Context

This filing reflects a routine disclosure of a passive investment by a major asset manager in a company operating within the healthcare diagnostics industry. It does not provide specific insights into broader industry trends or competitive dynamics beyond the fact that QuidelOrtho Corp. is a publicly traded entity attracting institutional investment.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional ownership stake, potentially influencing market perception of the stock's liquidity and institutional interest.

Key Dates

Keywords

QuidelOrtho Corp, BlackRock Inc, Schedule 13G, beneficial ownership, common stock, institutional investor, passive investment, healthcare diagnostics